B And G Foods Inc (BGS) valuation
B And G Foods P/E ratio history
B And G Foods has no meaningful price to earnings ratio at the last close, which happens when earnings over the last twelve months are negative or close to zero. At its last 6 fiscal year ends its P/E ranged from 10.8 (year to Dec 2017) to 30.1 (year to Jan 2022), with a median of 14.5.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Jan 3, 2026 | $4.20 | -$0.54 | n/m | 8.3 |
| Dec 28, 2024 | $7.09 | -$3.18 | n/m | 10.4 |
| Dec 30, 2023 | $10.50 | -$0.89 | n/m | 11.7 |
| Dec 31, 2022 | $11.15 | -$0.16 | n/m | 10.7 |
| Jan 1, 2022 | $30.73 | $1.02 | 30.1 | 15.2 |
| Jan 2, 2021 | $27.73 | $2.05 | 13.5 | — |
| Dec 28, 2019 | $18.22 | $1.18 | 15.4 | — |
| Dec 29, 2018 | $29.96 | $2.61 | 11.5 | — |
| Dec 30, 2017 | $35.15 | $3.26 | 10.8 | — |
| Dec 31, 2016 | $43.80 | $1.73 | 25.4 | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
B And G Foods valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| B And G FoodsBGS | $188M | — | 4.3 | 0.1 |
| Niagen BioscienceNAGE | $186M | 12.9 | — | 1.4 |
| LimoneiraLMNR | $194M | — | 61.4 | 1.5 |
| Natures Sunshine ProductsNATR | $215M | 12.1 | 10.6 | 0.4 |
| Nu Skin EnterprisesNUS | $226M | — | 4.7 | 0.2 |
| MedifastMED | $136M | — | — | 0.5 |
| Usana Health SciencesUSNA | $264M | — | 11.2 | 0.3 |
| AlicoALCO | $277M | 178.1 | — | 16.2 |
| Beyond MeatBYND | $119M | — | — | 0.5 |
| Peer median | 12.9 | 10.9 | 0.5 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: BGS financials · BGS returns
No forecast, no recommendation. This page describes B And G Foods Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.